Sanofi receives FDA approval for Tzield in paediatric diabetes
Sanofi has received approval from the US Food and Drug Administration (FDA) for a supplemental biologic licence application for Tzield…
23 Apr 2026
AbbVie opts for North Carolina to house $1.4bn manufacturing site
AbbVie has tapped North Carolina as the location for a new $1.4bn manufacturing site as part of its $100bn US manufacturing pledge – adding another giant to the growing list…
23 Apr 2026
MSD teams up with Google Cloud on agentic AI transformation
Merck & Co (MSD) and Google Cloud have formed a multi-year partnership, investing up to $1bn, to advance agentic AI enterprise transformation. The collaboration aims to implement an agentic platform across…
22 Apr 2026
Medicare weight loss drug pilot on ice as insurers decline to contribute
The Centers for Medicare & Medicaid Services (CMS) has hit pause on its pilot programme designed to offer insurer-fronted access to cheaper weight loss medications, as some insurance companies decline…
22 Apr 2026
MSD-backed Ray locks in $125m to back eye drug pipeline
Ray Therapeutics has secured $125m in a Series B funding round, as the gene therapy-focused biopharma eyes a breakout on the ophthalmology market. Through the oversubscribed round, which was led…
22 Apr 2026
FDA approves MSD’s once-daily HIV combo Idvynso
MSD (Merck & Co) has secured a US approval for its two-drug human immunodeficiency virus (HIV) combination therapy, Idvynso (doravirine/islatravir), as the company looks to secure a slice of the…
22 Apr 2026
BioAegis and Prenosis partner for inflammatory disease therapies
BioAegis Therapeutics has entered a strategic partnership with Prenosis to advance AI-driven precision medicine for inflammatory diseases. The collaboration will evaluate biomarkers and patient subgroups with improved responses to BioAegis’…